middle.news

How Will Osteopore’s Swiss Approval Transform Its European Ambitions?

8:37am on Monday 14th of July, 2025 AEST Healthcare
Read Story

How Will Osteopore’s Swiss Approval Transform Its European Ambitions?

8:37am on Monday 14th of July, 2025 AEST
Key Points
  • Swiss market approval under EU MDR achieved
  • Completes Osteopore’s European product portfolio
  • Exclusive distribution partnership with Zimmer Biomet expanded
  • Targets growing cranial implant market in Europe
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Osteopore (ASX:OSX)
OPEN ARTICLE